Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

PHASE4RecruitingINTERVENTIONAL

Enrollment

606

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions

TraumaSurgeryDeep Vein Thrombosis (DVT)Thromboembolic Events

Interventions

DRUG

Enoxaparin Sodium Injection 30 mg BID

DRUG

Enoxaparin Sodium Injection 40 mg QD

Trial Locations (1)

RECRUITING

Oregon Health & Science University, Portland

All Listed Sponsors

lead

Oregon Health and Science University

OTHER